Zomedica Corp. (ZOMDF) Discusses the Equine Veterinary Market Opportunity Transcript

Understand this faster with AI
SA Transcripts159.14K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Zomedica Corp. (ZOMDF) Discusses the Equine Veterinary Market Opportunity March 27, 2026 4:00 PM EDT Company Participants Larry Heaton - President, CEO & DirectorPaul TyeTrudy GageRoderick RichardsT. J. BarclayKimberly KeetonMike Zuehlke - Senior VP of Finance & Corporate Controller Presentation Unknown Executive Hello, everyone. I hope everyone can hear me. As you can see, we've been having some technical difficulties, and we've been trying to restart so that you can hear the sound. We are going to have to restart the webinar. So we'll do that hopefully, then we can get sound for the prerecorded version of the webinar. So we're going to go ahead and restart the webinar. So you might get booted off and you'll have to come back in. Larry HeatonPresident, CEO & Director Let's give people a chance to get back in. Wait like a minute. Okay, we're getting close. So go ahead and start it because this first part, these people have seen a few times before. All right? Yes. Okay. All right, go.
Unknown Attendee Current and potential investors that we will be making various remarks about future expectations, plans and prospects that are considered forward-looking statements. There are risks that actual results may differ from these statements. We refer you to the safe harbor statement on screen or to the Risk Factors sections of our public filings, which can be found on our website under Investor filings, EDGAR and SEDAR+. The statements are made as of today, March 27, 2026, and reflect our expectations as of today. Thank you for joining us for Zomedica's investor webinar series. We're excited to have you with us as we take a closer look at our company, our innovative product platforms and the passionate people driving our success. This series is designed to give you a deeper
Source Information
Discussion
0 professional contributions
Sign in to join this professional discussion.
Be the first to add a constructive contribution.
